Skip to content

Precision Medical Ventures

4 viewers · 30d

Total raised

$500K

1 filing since 2025 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $500K
ROUNDS
1
INVESTORS
2
FOUNDED
2021
HQ
Seattle, WA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
4

AI overview

Updated

Precision Medical Ventures Inc. (PMV) is an innovative investment group dedicated to advancing medical technology, particularly within the realms of radiology and healthcare. The company is committed to enhancing patient care and outcomes by developing cutting-edge medical devices and software solutions that address critical challenges in healthcare delivery.

What sets it apart

PMV stands out for introducing RevealAI-Lung, the world's first regulatory-cleared CADx software for lung nodule characterization, which significantly enhances diagnostic accuracy and reduces healthcare costs.

Funding history

1 round
SAFE+2Mar 14, 2025
Form D
+$500K$500K total

Latest SEC filings

via EDGAR · CIK 0001885740
Form D · Mar 14, 2025View on EDGAR

Products

1 tracked

RevealAI-Lung

Diagnostic Software

RevealAI-Lung is a revolutionary computer-aided diagnosis (CADx) software designed specifically for the characterization of lung nodules. It employs advanced algorithms to analyze lung CT scans with high precision, addressing the critical need for accurate assessment and management of lung nodules that could indicate cancer.

  • World's first CADx software for lung nodule characterization to receive regulatory clearance
  • Improves diagnostic precision for better treatment outcomes
  • Significantly reduces healthcare costs associated with lung nodule management
  • Scientifically validated to enhance patient outcomes